Ta‐Chung Chao

机构：National Yang Ming Chiao Tung University, Taipei Veterans General Hospital, Taipei Medical University-Shuang Ho Hospital, Taipei Medical University · ORCID：0000-0003-1451-1939

发表论文 171 篇 · 总被引 2137 次 · h-index 26

代表论文

Giredestrant for Estrogen Receptor–Positive, HER2-Negative, Previously Treated Advanced Breast Cancer: Results From the Randomized, Phase II acelERA Breast Cancer Study (2024 · Journal of Clinical Oncology · 被引 70)
Real-world outcomes of everolimus-based treatment in a Taiwanese cohort with metastatic HR+/HER2− breast cancer (2024 · Journal of the Chinese Medical Association · 被引 8)
HDAC inhibitors modulate Hippo pathway signaling in hormone positive breast cancer (2025 · Clinical Epigenetics · 被引 7)
Correlation Between PIK3R1 Expression and Cell Growth in Human Breast Cancer Cell Line BT-474 and Clinical Outcomes (2025 · World Journal of Oncology · 被引 2)
Ferroptosis as a therapeutic vulnerability in MDM2 inhibition in dedifferentiated liposarcoma (2025 · Oncology Letters · 被引 1)
Genetic Alterations in HER2-Positive and Equivocal Breast Cancer by Immunohistochemistry (2025 · Breast Cancer Targets and Therapy · 被引 1)